Insmed remains a Buy, with an enterprise value near $30B and robust growth driven by Brinsupri and pipeline assets. Learn ...

TOA Pharmaceuticals is expanding globally through integrated OEM drug manufacturing, rigorous quality control, and pioneering ...

United Therapeutics jumps 12.5% as phase III TETON-1 data show strong lung function gains for Tyvaso in IPF, paving the way ...

Insmed Incorporated (NASDAQ:INSM) is one of the best high growth healthcare stocks to buy now. Stifel raised the price target on Insmed Incorporated (NASDAQ:INSM) to $208 from $205 on March 24, ...

Insmed (INSM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

How to step up asthma treatment in a child who can't use a dry powder inhaler (DPI) licensed for Maintenance and Reliever ...

As health systems seek to balance innovation with the need to address sustainability, increasing attention is being paid to ...

Collaboration combines Flurry’s leading spray drying innovation with Experic’s GMP manufacturing to accelerate ...

Please provide your email address to receive an email when new articles are posted on . Risk for first moderate/severe COPD exacerbation was lower among dry powder vs. metered-dose or soft mist ...

Detailed price information for Cspc Pharm Group Ltd Ord (CHJTF) from The Globe and Mail including charting and trades.

Detailed price information for Cspc Pharm Group Ltd Ord (CHJTF) from The Globe and Mail including charting and trades.

Introduction Inhaler technique proficiency is crucial for the effective management of asthma and COPD. Despite the widespread use of inhalers, incorrect usage remains prevalent among healthcare ...